Articles published on arginase 1 deficiency (ARG1-D)
A new study from IHE has recently been published in two articles that provides additional insights into the ultra-rare disease arginase 1 deficiency (ARG1-D). This is a metabolic disease which may cause spastic paraplegia, cognitive deficiency, seizures, and ultimately severe disability.
In a European survey study of 21 individuals with ARG1-D, it was shown that this disease may cause severe cognitive and mobility impairment which has an impact on quality of life, societal costs, and caregiver burden. The study was a collaboration between IHE, Immedica Pharma AB and ARG1-D clinical expertise at hospitals in Europe.
Read more and download the articles:
